论文信息 - Cancer Therapy : Preclinical Antitumor Efficacy of PKI-587 , a Highly Potent Dual PI 3 K / mTOR Kinase Inhibitor - 字舞流文

Cancer Therapy : Preclinical Antitumor Efficacy of PKI-587 , a Highly Potent Dual PI 3 K / mTOR Kinase Inhibitor

L. Feldberg | R. Mallon | J. Lucas | S. Ayral-Kaloustian | I. Hollander | Zecheng Chen | A. Venkatesan | E. D. Santos | C. Dehnhardt | Inder Chaudhary | O. Santos | Larry R. Feldberg